Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine learning
Karan Ahuja, Gulam M Rather, Zhongtian Lin, Jianye Sui, Pengfei Xie, Tuan Le, Joseph R Bertino, Mehdi Javanmard, Karan Ahuja, Gulam M Rather, Zhongtian Lin, Jianye Sui, Pengfei Xie, Tuan Le, Joseph R Bertino, Mehdi Javanmard
Abstract
We present a novel method to rapidly assess drug efficacy in targeted cancer therapy, where antineoplastic agents are conjugated to antibodies targeting surface markers on tumor cells. We have fabricated and characterized a device capable of rapidly assessing tumor cell sensitivity to drugs using multifrequency impedance spectroscopy in combination with supervised machine learning for enhanced classification accuracy. Currently commercially available devices for the automated analysis of cell viability are based on staining, which fundamentally limits the subsequent characterization of these cells as well as downstream molecular analysis. Our approach requires as little as 20 μL of volume and avoids staining allowing for further downstream molecular analysis. To the best of our knowledge, this manuscript presents the first comprehensive attempt to using high-dimensional data and supervised machine learning, particularly phase change spectra obtained from multi-frequency impedance cytometry as features for the support vector machine classifier, to assess viability of cells without staining or labelling.
Keywords: Electrical and electronic engineering; Sensors.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
© The Author(s) 2019.
Figures
References
- Wagman, L. D. Principles of surgical oncology in Pazdur R., Wagman L. D., Camphausen K. A. & Hoskins W. J. (eds) Cancer Management: A Multidisciplinary approach. 11th edn (UBM Medica, Norwalk, CT, USA, 2008).
- Airley, R. Cancer chemotherapy: Basic science to the clinic. Churchill Livingstone; 6th edn (Wiley-Blackwell, Hoboken, NJ, 2009).
- Bomford, C. K., Kunkler, I. H. & Walter, J. Walter and Miller’s Textbook of Radiation Therapy 6th edn, page 311.
- Brunton, L. L. (ed.) John, S. Lazo & Keith, L. Parker, Associate Editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics 11th edn, United States of America: The McGraw-Hill Companies, Inc. (2006).
- NCI Dictionary of Cancer Terms. National Cancer Institute, .
- NCI Dictionary of Cancer Terms. National Cancer Institute. .
- Lin, S.-Y., Bertino, J. R., Lin, C.-Y. Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies. Google patents (2016).
- Bertino, J. R., Lin, S.-Y., Lin, C.-Y. Targeted delivery of doxorubicin conjugated with anti-matriptase antibody to treat multiple myeloma. Proceedings: AACR 101st Annual Meeting (Washington, DC, 2010).
- van Meerloo, J., Kaspers, G. J. L. & Cloos, J. Cell sensitivity assays: the MTT assay. In: Cree I. (eds) Cancer Cell Culture. Methods in Molecular Biology (Methods and Protocols), vol 731 (Humana Press, 2011).
- “Cell Viability.” Bioluminescent Reporters, .
- Sawyers C. Targeted cancer therapy. Nature. 2004;432:294–297. doi: 10.1038/nature03095.
- Miller OJ, et al. High-resolution dose-response screening using droplet-based microfluidics. Proc. Natl Acad. Sci. USA. 2012;109:378–383. doi: 10.1073/pnas.1113324109.
- Ding Y, et al. Microfluidic-enabled print-to-screen (P2S) platform for high-throughput screening of combinatorial chemotherapy. Anal. Chem. 2015 doi: 10.1021/acs.analchem.5b00826.
- Ozkumur AY, Goods BA, Love JC. Development of a high-throughput functional screen using nanowell-assisted cell patterning. Small. 2015;11:4643–4650. doi: 10.1002/smll.201500674.
- Matsumoto Y, et al. A microfluidic channel method for rapid drug-susceptibility testing of pseudomonas aeruginosa. PLoS ONE. 2016;11:e0148797. doi: 10.1371/journal.pone.0148797.
- Eriksson A, et al. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia. Blood Cancer J. 2015;5:e307. doi: 10.1038/bcj.2015.31.
- Xu ZY, et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials. 2013;34:4109–4117. doi: 10.1016/j.biomaterials.2013.02.045.
- Khin ZP, et al. A preclinical assay for chemosensitivity in multiple myeloma. Cancer Res. 2014;74:56–67. doi: 10.1158/0008-5472.CAN-13-2397.
- Jonas O, et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci. Transl. Med. 2015;7:284ra257. doi: 10.1126/scitranslmed.3010564.
- Ada Hang-Heng Wong, et al. Drug screening of cancer cell lines and human primary tumors using droplet microfluidics. Nat. Sci. Rep. 2017;7:1–12. doi: 10.1038/s41598-016-0028-x.
- Yookyung Jung, et al. Longitudinal, label-free, quantitative tracking of cell death and viability in a 3D tumor model with OCT. Nat. Sci. Rep. 2016;6:1–8. doi: 10.1038/s41598-016-0001-8.
- Yang L, Banadana P, Bhunia A, Bashir R. Effects of dielectropheresis on growth, viability and immuno-reactivity of listeria monocytogens. J. Biol. Eng. 2008;2:6. doi: 10.1186/1754-1611-2-6.
- Mernier, G. et al. Cell viability assessment by flow cytometry using yeast as cell model. Sens. Actuators B Chem. (2009).
- Höber R. Eine Methode die elektrische Leitfaehigkeit im Innern von Zellen zu messen. Arch. Gesamte Physiol. 1910;133:237–259. doi: 10.1007/BF01680330.
- Höber R. Ein zweites Verfahren die Leitfaehigkeit im Innern von Zellen ze messem. Arch. Gesamte Physiol. 1912;148:189–221. doi: 10.1007/BF01680784.
- Sun T, Morgan H. Single-cell microfluidic impedance cytometry: a review. Microfluid Nanofluid. 2010;8:423–443. doi: 10.1007/s10404-010-0580-9.
- Holmes D, et al. Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry. Lab Chip. 2009;9:2881–2889. doi: 10.1039/b910053a.
- Evander M, Ricco AJ, Morser J, Kovacs GT, Leung LL, Giovangrandi L. Microfluidic impedance cytometer for platelet analysis. Lab Chip. 2013;13:722–729. doi: 10.1039/c2lc40896a.
- Simon P, Frankowski M, Bock N, Neukammer J. Label-free whole blood cell differentiation based on multiple frequency AC impedance and lightscattering analysis in a micro flow cytometer. Lab Chip. 2016;16:2326–2338. doi: 10.1039/C6LC00128A.
- Xie P, Cao X, Lin Z, Javanmard M. Top-down fabrication meets bottom-up synthesis for nanoelectronic barcoding of microparticles. Lab Chip. 2017;17:1939–1947. doi: 10.1039/C7LC00035A.
- Zhao Y, et al. Tumor cell characterization and classification based on cellular specific membrane capacitance and cytoplasm conductivity. Biosens. Bioelectron. 2014;57:245–253. doi: 10.1016/j.bios.2014.02.026.
- Lin Z, Cao X, Xie P, Liu M, Javanmard M. PicoMolar level detection of protein biomarkers based on electronic sizing of beadaggregates: theoretical and experimental considerations. Biomed. Microdevices. 2015;17:119. doi: 10.1007/s10544-015-0022-2.
- David F, Hebeisen M, Schade G, Franco‐Lara E, Di Berardino M. Viability and membrane potential analysis of Bacillus megaterium cells by impedance flow cytometry. Biotechnol. Bioeng. 2012;109:483–492. doi: 10.1002/bit.23345.
- Cotres C, Vapnik V. Support-vector networks. Mach. Learn. 1995;20:273–297.
- Wong SL, et al. Combining biological networks to predict genetic interactions. Proc. Natl Acad. Sci. USA. 2004;101:15682–15687. doi: 10.1073/pnas.0406614101.
- Middendorf, M., Kundaje, A., Wiggins, C., Freund, Y. & Leslie, C. Predicting genetic regulatory response using classification. Bioinformatics20, i232–i240 (2004).
- Allen JE, et al. JIGSAW, GeneZilla, and GlimmerHMM: puzzling out the features of human genes in the ENCODE regions. Genome Biol. 2006;7:S9. doi: 10.1186/gb-2006-7-s1-s9.
- Leelatian N, et al. Preparing viable single cells from human tissue and tumors for cytomic analysis. Curr. Protoc. Mol. Biol. 2017;118:25C.1.–25C.1.23..
Source: PubMed